Drugs / Oxacom
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06683040 | Jun 2024 → Dec 2027 expected | pulmonary arterial hypertension | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxacom | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06683040 ↗ |
| Route | Intravenous | “intravenous administration” NCT06683040 ↗ |